Invention Grant
- Patent Title: Treatment of depressive disorders
-
Application No.: US13669353Application Date: 2012-11-05
-
Publication No.: US10010584B2Publication Date: 2018-07-03
- Inventor: Miao-Kun Sun , Daniel L Alkon
- Applicant: Blanchette Rockefeller Neuroscience Institute
- Applicant Address: US WV Morgantown
- Assignee: West Virginia University
- Current Assignee: West Virginia University
- Current Assignee Address: US WV Morgantown
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Main IPC: A61K31/335
- IPC: A61K31/335 ; A61K31/351 ; A61K31/357 ; A61K31/366 ; A61K38/18 ; A61K31/045 ; A61K31/05 ; A61K31/192 ; A61K31/196 ; A61K31/365 ; A61K31/4164 ; A61K31/4172
Abstract:
The invention provides for the use of carbonic anhydrase activators; protein kinase C activators and FGF-18 to treat depressive disorders. The invention also relates to improved animal models and methods for screening and identifying compounds to treat depressive disorders.
Public/Granted literature
- US20130165375A1 TREATMENT OF DEPRESSIVE DISORDERS Public/Granted day:2013-06-27
Information query
